CMRX
Closed
Chimerix Inc
8.54
0.00 (0.00%)
Last Update: 21 Apr 2025 16:30:00
Yesterday: 8.54
Day's Range: 8.54 - 8.54
Send
sign up or login to leave a comment!
When Written:
1.26
Chimerix Inc. is a biopharmaceutical company that focuses on developing antiviral therapies to treat life-threatening diseases. The company's lead product, brincidofovir, is an antiviral drug that is being developed to treat cytomegalovirus (CMV) infections in transplant patients. Chimerix is also developing therapies for other viral infections, including adenovirus, BK virus, and smallpox. The company was founded in 2000 and is headquartered in Durham, North Carolina. Chimerix is publicly traded on the NASDAQ stock exchange under the ticker symbol CMRX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








